塞马格卢提德通过恢复Cx43表达来减弱糖尿病心肌病的病态电生理学重塑
Meiling Yan1, Kaibin Lin2, Dong Huang3
1Department of Cardiology, Huadong Hospital Affiliated to Fudan University, Shanghai, 200040, China.
Endocrine
|April 22, 2024
概括
塞马格卢提德通过减少氧化应激和亡来改善糖尿病小鼠的心脏功能. 它还恢复了连接素43 (Cx43) 的表达,改善了糖尿病心肌病中的电生理学重塑.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 糖尿病心肌病 (DCM) 是糖尿病的一个重要并发症.
- 作为一种抗高血糖剂的塞马格卢提德 (semaglutide) 显示出潜在的心脏保护作用.
- 塞马格卢提德对DCM的影响的精确机制,特别是关于Cx43和电生理学,需要阐明.
研究的目的:
- 在DCM的小鼠模型中研究塞马格卢提德对心肌损伤和心脏功能的影响.
- 探索潜在的机制,重点关注连接素43 (Cx43) 表达和电生理学重塑.
- 评估Sirt1/AMPK途径在塞马格卢提德心脏保护作用中的作用.
主要方法:
- 在C57BL/6小鼠中使用链杆菌素诱导1型糖尿病.
- 在糖尿病小鼠中,为期8周,每周皮下注射塞马格卢提德 (0.15毫克/公斤).
- 评估血糖,心脏功能,氧化应激,亡,Sirt1/AMPK通路激活,Cx43表达和心电图 (ECG) 参数.
主要成果:
- 在糖尿病小鼠中,塞马格卢提德治疗显著改善了葡萄糖代谢和心脏功能.
- 它改善了糖尿病心脏中的氧化应激和亡.
- 赛马格卢提德激活了Sirt1/AMPK通路,恢复了心肌Cx43表达,并逆转了心电图异常,包括延长RR,QRS,QT和QTc间隔.
结论:
- 塞马格卢提德在糖尿病心脏中表现出对氧化应激和亡的保护作用.
- 这些行动有助于改善心脏功能和DCM中的电生理学重塑.
- 心脏保护作用可能通过激活Sirt1/AMPK通路和恢复Cx43表达来调节.
相关概念视频
01:24Glucagon-like Receptor Agonists
1.3K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805